^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BNT114

    i
    Associations
    News

    Trials

    Company:
    BioNTech
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID (TNBC-MERIT) (NCT02316457)
    Phase 1
    BioNTech SE
    Completed
    Last update posted :
    07/19/2023
    Initiation :
    10/01/2016
    Primary completion :
    05/13/2020
    Completion :
    05/17/2023
    HER-2 • ER • PGR
    |
    HER-2 negative
    |
    BNT114 • IVAC_M_uID